SWOG clinical trial number
SWOG-8788
Phase III Evaluation of "High Dose" versus "Standard Dose" Cisplatin Combined with Bleomycin and VP-16 for Advanced Metastatic Testicular Cancer
Closed
Phase
Published
Abbreviated Title
Phase III Evaluation of "High Dose" versus "Standard Dose" Cisplatin Combined with Bleomycin and VP-16 for Advanced Metastatic Testicular Cancer
Activated
01/15/1988
Closed
09/15/1989
Publication Information Expand/Collapse
1991
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol.
1990
Phase III study of cisplatin dose intensity in advanced germ cell tumors (GCT). A Southeastern and Southwest Oncology Group protocol.